VIA
BMY icon

Vantis Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Vantis Investment Advisers’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-166,500
Closed -$9.79M – 21
2020
Q2 		$9.79M Buy
+166,500
New +$9.96M 8.12% 4

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Vantis Investment Advisers's BMY Position: Q3 2020 in Review

Vantis Investment Advisers sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 166,500 shares — an estimated $9.79M sold.

Vantis Investment Advisers first reported a position in BMY in Q2 2020 and held it in 1 quarter. The position peaked at $9.79M in Q2 2020. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Vantis Investment Advisers reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
  • Vantis Investment Advisers sold 166,500 Bristol-Myers Squibb shares in Q3 2020, an estimated $9.79M.
  • Vantis Investment Advisers first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 1 quarter.
  • Vantis Investment Advisers's Bristol-Myers Squibb position peaked at $9.79M in Q2 2020.
  • 2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Vantis Investment Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.